Results of a randomized, double-blind study of romiplostim versus placebo in patients with low/intermediate-1-risk myelodysplastic syndrome and thrombocytopenia (2014)
Attributed to:
MRC Centre for Transplantation
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1002/cncr.28663
PubMed Identifier: 24706489
Publication URI: http://europepmc.org/abstract/MED/24706489
Type: Journal Article/Review
Parent Publication: Cancer
Issue: 12
ISSN: 0008-543X